Dacryocystitis caused by community-onset methicillin-resistant Staphylococcus aureus

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 5, 2005, Pages 371-375

  Kotlus, Brett S ^a   Rodgers, I Rand ^b,c   Udell, Ira J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; POVIDONE IODINE; TETRACYCLINE; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; DACRYOCYSTITIS; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; COMMUNITY-ACQUIRED INFECTIONS; CONJUNCTIVITIS, BACTERIAL; DACRYOCYSTITIS; DACRYOCYSTORHINOSTOMY; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 26844514764     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000175035.22953.71     Document Type: Review

References (30)

1. Eiferman RA, O'Neill KP, Morrison NA. Methicillin-resistant Staphylococcus aureus corneal ulcers. Ann Ophthalmol 1991;23: 414-5.
2. Fukuda M, Ohashi H, Matsumoto C, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea 2002;21(Suppl 7):S86-9.
3. Oshima Y, Ohiji M, Inoue Y, et al. Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis. Ophthalmology 1999;106:142-7.
4. Kubo M, Sakuraba T, Arai Y, Nakazawa M. Dacryocystorhinostomy for dacryocystitis caused by methicillin-resistant Staphylococcus aureus: report of four cases. Jpn K Ophthalmol 2002;46: 177-82.
5. Coden DJ, Hornblass A, Haas BD. Clinical bacteriology of dacryocystitis in adults. Ophthal Plast Reconstr Surg 1993;9:125-31.
6. Blicker JA, Buffam FV. Lacrimal sac, conjunctival, and nasal culture results in dacryocystorhinostomy patients. Ophthal Plast Reconstr Surg 1993;9:43-6.
7. Huber-Spitzy V, Steinkogler FJ, Huber E, Arocker-Mettinger E. Acquired dacryocystitis: microbiology and conservative therapy. Acta Ophthalmol 1992;70:745-9.
8. Mauriello JA, Wasserman BA. Acute dacryocystitis: an unusual case of life-threatening orbital intraconal abscess with frozen globe. Ophthal Plast Recontr Surg 1996;12:294-5.
9. Cahill KV, Burns JA. Management of acute dacryocystitis in adults. Ophthal Plast Reconstr Surg 1993;9:38-42.
10. Schaaff F, Reipert A, Bierbaum G. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:3540-8.
11. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;9:486-93.
12. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
13. Downes A, Thornhill C, Mallard RH. An evaluation of Vitek: an automated system for bacterial identification and susceptibility testing. Commun Dis Public Health 1998;1:206-7.
14. Jernigan JA. et al Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
15. Saitoh A, Jinbayashi H, Saitoh AK, et al. Parameter estimation and dosage adjustment in the treatment with vancomycin of methicillin-resistant Staphylococcus aureus ocular infections. Ophthalmologica 1997;211:232-5.
16. Itoh M, Aoyama T, Iemoto A, et al. Pharmaceutical investigation of vancomycin hydrochloride eye drops and their topical application to MRSA eye infection [in Japanese]. Yakugaku Zasshi 2001; 121:433-9.
17. Stephens DL, Herr D, Lampiris H, et al. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481-90.
18. Vinken A, Li Z, Balan D, et al. Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model. J Hosp Infect 2001;49(Suppl A):S13-24.
19. Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:1714-8.
20. Akins RL, Rybak MJ. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model. Antimicrob Agents Chemother 2000;44:1925-9.
21. Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician 2003;65:455-64.
22. Entenza JM, Que YA, Vouillamoz J, et al. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob Agents Chemother 2001;45:3076-83.
23. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-6.
24. Tungsiripat T, Sarayba MA, Kaufman MB, et al. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model. Am J Ophthalmol 2003; 136:76-81.
25. Dajcs JJ, Thibodeaux BA, Hume EB, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res 2001;22:451-7.
26. Dajcs JJ, Hume EB, Moreau JM, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci 2000;41:1432-7.
27. Hurwitz JJ, Rodgers KJA. Management of acquired dacryocystitis. Can J Ophthalmol 1983;18:213-6.
28. Boynton JR, Anawis MA. Role of dacryocystectomy in the management of failed dacryocystorhinostomy associated with chronic dacryocystitis. Ophthalmic Surg Lasers 1996;27:133-6.
29. Mauriello JA, Vadehra VK. Dacryocystectomy: surgical indications and results in 25 patients. Ophthal Plast Reconstr Surg 1997;13:216-20.
30. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.